がん医療におけるゲノミクスの世界市場レポート 2024年

がん医療におけるゲノミクス市場規模は近年急成長しています。2023年の150億8,000万米ドルから2024年には177億9,000万米ドルへと、CAGR18.0％で拡大します。過去の期間に見られた成長は、初期段階の研究開発、コンパニオン診断の確立、倫理的・法的枠組みの開拓、データの標準化と解釈の努力、市場の初期浸透に起因すると考えられます。

がん医療におけるゲノミクス市場が成長を遂げている背景には、がんにおけるゲノミクス研究への資金提供や投資の増加があります。がん医療におけるゲノミクス技術を推進する企業やイニシアチブには、多額の財源が向けられています。投資家は特に、包括的なゲノム・プロファイリングとがん進行の非侵襲的モニタリングを提供する次世代シーケンシング・プラットフォームからリキッドバイオプシー・アッセイに至るまで、革新的技術の支援に関心を寄せています。特筆すべきは、ゲノム研究を促進するために英国政府が約1億7,500万ポンドという多額の投資を行ったことで、最先端のゲノム・ヘルスケア・ソリューションに対する資金援助が増加していることです。このような資金と投資の流入は、がん医療におけるゲノミクス市場の成長を促進する重要な要因です。

2023年のがん医療におけるゲノミクス市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。がん医療におけるゲノミクス市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• がん治療市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• がん治療における世界のゲノミクスの市場規模実績と成長、2018年～2023年
• がん治療における世界のゲノミクス市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

• がん治療市場における世界のゲノミクス、製品タイプ別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 機器
• 消耗品
• サービス
• がん治療市場における世界のゲノミクス、技術別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• PCR（ポリメラーゼ連鎖反応）
• マイクロアレイ
• ゲノム配列決定
• その他の技術
• がん治療市場における世界のゲノミクス、用途別セグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 診断
• 個別化医療
• 創薬と開発
• 研究
• がん治療市場における世界のゲノミクス、エンドユーザー別のセグメンテーション、実績および予測、2018年～2023年、2023年～2028年、2033年
• 病院
• 政府機関
• 調査施設

第7章 地域および国の分析

• がん治療市場における世界のゲノミクス、地域別、実績および予測、2018年～2023年、2023年～2028年、2033年
• がん治療市場における世界のゲノミクス、国別、実績および予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん治療市場の競合情勢におけるゲノミクス
• がん治療市場におけるゲノミクス企業プロファイル
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Genomics In Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics in cancer care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics in cancer care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics in cancer care market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product Type: Instruments; Consumables; Services
• 2) By Technology: PCR (Polymerase Chain Reaction); MicroArrays; Genome Sequencing; Other Technologies
• 3) By Application: Diagnostics; Personalized Medicine; Drug Discovery And Development; Research
• 4) By End-user: Hospitals; Government Institutes; Research Facilities
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Genomics in cancer care involves the comprehensive examination of all variations in DNA sequence and gene expression between tumor cells and healthy host cells. This approach aims to identify patients' genetic backgrounds for more effective cancer treatment. Genomics in cancer care is utilized to detect cancer-causing mutations, improve tumor-specific diagnostic techniques and treatment plans, facilitate precision medicine research and drug development, and enable the creation of targeted therapies to offer personalized treatment to patients with various types of cancers.

The main product types in genomics for cancer care include instruments, consumables, and services. Instruments are devices or equipment used for the detection of tumors in cancer genomics, providing accurate diagnostics. Various technologies, such as PCR, microarrays, genome sequencing, and others, are employed in these instruments. The applications of genomics in cancer care span diagnostics, personalized medicine, drug discovery and development, and research. These applications are utilized by hospitals, government institutes, and research facilities to enhance cancer diagnosis and treatment strategies.

The genomics in cancer care market research report is one of a series of new reports from The Business Research Company that provides genomics in cancer care market statistics, including genomics in cancer care industry global market size, regional shares, competitors with a genomics in cancer care market share, detailed genomics in cancer care market segments, market trends and opportunities, and any further data you may need to thrive in the genomics in cancer care industry. This genomics in cancer care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics in cancer care market size has grown rapidly in recent years. It will grow from $15.08 billion in 2023 to $17.79 billion in 2024 at a compound annual growth rate (CAGR) of 18.0%. The growth observed in the historical period can be attributed to early-stage research and development, the establishment of companion diagnostics, the development of ethical and legal frameworks, efforts in data standardization and interpretation, and the initial penetration of the market.

The genomics in cancer care market size is expected to see rapid growth in the next few years. It will grow to $33.28 billion in 2028 at a compound annual growth rate (CAGR) of 17.0%. The anticipated growth in the forecast period can be attributed to the increasing prevalence of cancer, advancements in data analytics, the expanding market in emerging economies, concerns related to genomic data privacy and security, and ongoing improvements in healthcare infrastructure. Major trends expected in the forecast period include technological advancements, the rise of personalized medicine, the reduction in costs of genomic sequencing, increased regulatory support and guidelines, and a growing awareness and demand from patients for genomic-based healthcare solutions.

The genomics in cancer care market is witnessing significant growth due to the growing demand for cancer diagnostics. Cancer diagnostics, which involves identifying tumor characteristics and determining the right treatment plan, has become increasingly reliant on genomics in cancer care. This approach enables a deeper understanding of the genetic background of cancer patients, facilitating personalized and targeted treatment strategies. With millions of new cancer cases diagnosed annually in the United States, the demand for advanced genomics technologies in cancer care is escalating. Therefore, the market is expected to be driven by the continued need for precise and personalized cancer diagnostics.

The genomics in cancer care market is experiencing growth, propelled by an increase in funding and investments for genomics research in cancer. Significant financial resources are being directed towards companies and initiatives advancing genomics technologies in cancer care. Investors are particularly interested in supporting innovative technologies, ranging from next-generation sequencing platforms to liquid biopsy assays, which provide comprehensive genomic profiling and non-invasive monitoring of cancer progression. Notably, the UK government's substantial investment of around £175 million to boost genomics research underscores the increasing financial support for cutting-edge genomic healthcare solutions. This influx of funding and investments is a key factor driving the growth of the genomics in cancer care market.

Technological advancements are a key trend driving the growth of the genomics in cancer care market. Major players in the market are focusing on developing innovative next-generation sequencing technologies to enhance their market positions. For example, Personalis, Inc. launched NeXT Personal, a next-generation liquid biopsy assay with industry-leading sensitivity for detecting residual molecular disease (MRD) and cancer recurrence. This predictive biomarker provides significant improvements over existing methods, contributing to more accurate and sensitive cancer diagnostics. The ongoing trend of technological advancements in genomics is anticipated to positively impact the market by offering more effective and precise cancer care solutions.

Major companies operating in the genomics in cancer care market are engaging in strategic partnerships to strengthen their positions. These partnerships involve structured affiliations between commercial enterprises, often established through business agreements or contracts. The collaboration between C2i Genomics and Karkinos Healthcare exemplifies this trend, where innovative cancer detection technology is brought together with the goal of driving research and development (R&D), establishing future pharma partnerships, and facilitating clinical use in India. Such strategic partnerships contribute to the expansion and global scalability of genomics in cancer care technologies, fostering growth and development in the market.

In March 2021, Agilent Technologies Inc., a leading U.S.-based life sciences company, successfully acquired Resolution Bioscience Inc. for a total consideration of $550 million. This strategic acquisition significantly expands Agilent's product portfolio in Next-Generation Sequencing (NGS)-based cancer diagnostics. The integration of Resolution Bioscience's non-invasive liquid biopsy assay platform enables Agilent to address the evolving needs of patients through the development of innovative technologies for precision medicine. Resolution Bioscience Inc., headquartered in the United States, specializes in precision oncology technologies centered around Next-Generation Sequencing (NGS).

Major companies operating in the genomics in cancer care market report are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Danaher Corporation, Vyant Bio Inc., Pacific Biosciences of California Inc., Roche Holding AG, Quest Diagnostics Incorporated, DiaSorin S.p.A., BGI Group, Myriad Genetics Inc., Healthcare Global Enterprises Ltd., NeoGenomics Laboratories, Foundation Medicine Inc., Intermountain Healthcare, Laboratory Corporation of America Holdings, Flatiron Health Inc., Personal Genome Diagnostics Inc., Natera Inc., GRAIL Inc., Freenome Holdings Inc., Genomic Health Inc., Caris Life Sciences Inc., Tempus Labs Inc., OncoDNA S.A., Cancer Genetics Inc., Biocept Inc., GenomOncology Corp., OncoCyte Corporation, PathAI Inc., Enzyme Corporation, Karius Inc., N-of-One Inc., Oncora Medical Inc., Paradigm Diagnostics Inc., PierianDx Inc., Predicine Inc., Resolution Bioscience Inc., Strata Oncology Inc.

North America was the largest region in the genomics in cancer care market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics in cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genomics in cancer care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomics in the cancer care market consists of revenues earned by entities by providing sequencing to identify DNA and RNA alterations, and defining molecular subtypes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Genomics In Cancer Care Market Characteristics

3. Genomics In Cancer Care Market Trends And Strategies

4. Genomics In Cancer Care Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Genomics In Cancer Care Market Size and Growth

• 5.1. Global Genomics In Cancer Care Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Genomics In Cancer Care Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Genomics In Cancer Care Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Genomics In Cancer Care Market Segmentation

• 6.1. Global Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Instruments
• Consumables
• Services
• 6.2. Global Genomics In Cancer Care Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• PCR (Polymerase Chain Reaction)
• MicroArrays
• Genome Sequencing
• Other Technologies
• 6.3. Global Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Diagnostics
• Personalized Medicine
• Drug Discovery And Development
• Research
• 6.4. Global Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Government Institutes
• Research Facilities

7. Genomics In Cancer Care Market Regional And Country Analysis

• 7.1. Global Genomics In Cancer Care Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Genomics In Cancer Care Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Genomics In Cancer Care Market

• 8.1. Asia-Pacific Genomics In Cancer Care Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Genomics In Cancer Care Market

• 9.1. China Genomics In Cancer Care Market Overview
• 9.2. China Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Genomics In Cancer Care Market

• 10.1. India Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Genomics In Cancer Care Market

• 11.1. Japan Genomics In Cancer Care Market Overview
• 11.2. Japan Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Genomics In Cancer Care Market

• 12.1. Australia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Genomics In Cancer Care Market

• 13.1. Indonesia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Genomics In Cancer Care Market

• 14.1. South Korea Genomics In Cancer Care Market Overview
• 14.2. South Korea Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Genomics In Cancer Care Market

• 15.1. Western Europe Genomics In Cancer Care Market Overview
• 15.2. Western Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Genomics In Cancer Care Market

• 16.1. UK Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Genomics In Cancer Care Market

• 17.1. Germany Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Genomics In Cancer Care Market

• 18.1. France Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Genomics In Cancer Care Market

• 19.1. Italy Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Genomics In Cancer Care Market

• 20.1. Spain Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Genomics In Cancer Care Market

• 21.1. Eastern Europe Genomics In Cancer Care Market Overview
• 21.2. Eastern Europe Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Genomics In Cancer Care Market

• 22.1. Russia Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Genomics In Cancer Care Market

• 23.1. North America Genomics In Cancer Care Market Overview
• 23.2. North America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Genomics In Cancer Care Market

• 24.1. USA Genomics In Cancer Care Market Overview
• 24.2. USA Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Genomics In Cancer Care Market

• 25.1. Canada Genomics In Cancer Care Market Overview
• 25.2. Canada Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Genomics In Cancer Care Market

• 26.1. South America Genomics In Cancer Care Market Overview
• 26.2. South America Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Genomics In Cancer Care Market

• 27.1. Brazil Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Genomics In Cancer Care Market

• 28.1. Middle East Genomics In Cancer Care Market Overview
• 28.2. Middle East Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Genomics In Cancer Care Market

• 29.1. Africa Genomics In Cancer Care Market Overview
• 29.2. Africa Genomics In Cancer Care Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Genomics In Cancer Care Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Genomics In Cancer Care Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Genomics In Cancer Care Market Competitive Landscape And Company Profiles

• 30.1. Genomics In Cancer Care Market Competitive Landscape
• 30.2. Genomics In Cancer Care Market Company Profiles
  • 30.2.1. Illumina Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Agilent Technologies Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. PerkinElmer Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. QIAGEN N.V
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Genomics In Cancer Care Market Competitive Benchmarking

32. Global Genomics In Cancer Care Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Genomics In Cancer Care Market

34. Genomics In Cancer Care Market Future Outlook and Potential Analysis

• 34.1 Genomics In Cancer Care Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Genomics In Cancer Care Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Genomics In Cancer Care Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer